Cargando…

What clinicopathological factors affect the recurrence of hepatocellular carcinoma after surgery?

Detalles Bibliográficos
Autores principales:	Deng, Min, Li, Shaohua, Wei, Wei, Guo, Rongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708474/ https://www.ncbi.nlm.nih.gov/pubmed/36467358 http://dx.doi.org/10.21037/atm-22-3473

Ejemplares similares

Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
por: Deng, Min, et al.
Publicado: (2023)

Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study
por: Deng, Min, et al.
Publicado: (2023)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

A nomogram for predicting recurrence of primary hepatocellular carcinoma after resection
por: Dai, Yunlong, et al.
Publicado: (2023)

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma
por: Yao, Jian, et al.
Publicado: (2017)

High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma
por: Deng, Min, et al.
Publicado: (2021)

The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2022)

Fibrolamellar hepatocellular carcinoma presenting with early recurrent thrombosis
por: Kundakcioglu, Hacer, et al.
Publicado: (2022)

Recall Activity: What Happens Before and After Basal Cell Carcinomas’ Surgery?
por: Bocchiotti, Maria Alessandra, et al.
Publicado: (2017)

MT4‐MMP in tumor‐associated macrophages is linked to hepatocellular carcinoma aggressiveness and recurrence
por: Qi, Feng, et al.
Publicado: (2020)

Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
por: Yao, Shan, et al.
Publicado: (2022)

Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer
por: Keum, Min Ae, et al.
Publicado: (2012)

Ectopic hepatocellular carcinoma of the right adrenal gland: a case description
por: Gan, Leijuan, et al.
Publicado: (2023)

The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma
por: He, Tao, et al.
Publicado: (2022)

A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Clinicopathological Analysis of Factors Predictive of Recurrence and Outcome After Surgery
por: Zeng, Hong, et al.
Publicado: (2015)

Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma”
por: Yang, Yun, et al.
Publicado: (2023)

Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases
por: Li, Shaohua, et al.
Publicado: (2019)

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
por: Shaohua, Li, et al.
Publicado: (2015)

Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early‐stage hepatocellular carcinoma
por: Kakisaka, Tatsuhiko, et al.
Publicado: (2021)

Treatments for recurrent hepatocellular carcinoma: laparoscopic or open repeat liver resection, how to make a decision?
por: Zhang, Chenhao, et al.
Publicado: (2023)

Cutaneous Metastasis of Hepatocellular Carcinoma Following Skin Injury after Transcatheter Arterial Chemoembolization
por: Cho, Eujin, et al.
Publicado: (2013)

Prognostic, clinicopathological, and immune correlation of NLRP3 promoter methylation in kidney renal clear cell carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Simvastatin versus triptorelin in prevention of pain recurrences after surgery for endometriosis
por: Kargar, Mona, et al.
Publicado: (2013)

Nomograms based on clinicopathological factors and inflammatory indicators for prediction of early and late recurrence of hepatocellular carcinoma after surgical resection for patients with chronic hepatitis B
por: Dai, Tianxing, et al.
Publicado: (2021)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
por: Hao, Ke, et al.
Publicado: (2009)

Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
por: Moghaddam, Sara Tahbazzadeh, et al.
Publicado: (2023)

Recognising the clinically significant macrotrabecular massive variant of hepatocellular carcinoma
por: Seow, Dominique Yuan Bin, et al.
Publicado: (2022)

Repeated massive epistaxis after re-irradiation in recurrent nasopharyngeal carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2014)

Risk Factors and Incidence of Hepatocellular Carcinoma in Southeast Iran
por: Saiedi Hosseini, Seyed Yasser
Publicado: (2011)

Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Yi, Jun Ho, et al.
Publicado: (2021)

Identification of IRF8 as an immune infiltration‐related biomarker in hepatocellular carcinoma by bioinformatics analysis
por: Zhang, Renyu, et al.
Publicado: (2022)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma
por: Liang, Lei, et al.
Publicado: (2021)

Cardiac surgery: What the future holds?
por: Parissis, Haralabos
Publicado: (2011)

Long-Term Regression after Discontinuation of Regorafenib Administered for Sorafenib-Refractory Hepatocellular Carcinoma
por: Bae, Heewon, et al.
Publicado: (2023)

Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
por: Imamura, Hiroshi, et al.
Publicado: (2022)

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a87523578go7c28mai476gqvck